Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/14/1999 | CA2117795C Gustducin materials and methods |
12/14/1999 | CA2095642C Adhesion receptors for pathogenic or opportunistic microorganisms |
12/14/1999 | CA2092720C Macrophage activating factor from vitamin d binding protein |
12/14/1999 | CA2089161C Separation of proteins and dyes |
12/14/1999 | CA2084186C Purification of human interleukin-4 secreted from a escherichia coli mutant |
12/14/1999 | CA2081028C Cd2 binding domain of lymphocyte function associated antigen 3 |
12/14/1999 | CA2065150C Inhibitors of thrombin |
12/14/1999 | CA2033176C Growth hormone fusion proteins |
12/14/1999 | CA2030810C Grf analogs viia |
12/14/1999 | CA1340852C Process for purifying primate gm-csf protein |
12/14/1999 | CA1340848C Pseudorabies virus protein |
12/14/1999 | CA1340847C Adhesin antigens |
12/12/1999 | CA2273047A1 New strains "fil", stress-resistant under fermentation and/or growth conditions |
12/12/1999 | CA2272599A1 Rice gene resistant to blast disease |
12/10/1999 | CA2254178A1 Atp-sensitive potassium channel gene-defective animals |
12/10/1999 | CA2253641A1 Dna fragment, recombinant dna, and transformed plant |
12/09/1999 | WO1999063346A1 Method and device for electrochemical immunoassay of multiple analytes |
12/09/1999 | WO1999063099A1 Functional expression of adenosine receptors in yeast |
12/09/1999 | WO1999063098A1 Recombinant venezuelan equine encephalitis virus vaccine |
12/09/1999 | WO1999063095A1 Nucleic acid vaccines for prevention of flavivirus infection |
12/09/1999 | WO1999063094A2 Nucleotide and protein sequences of gpr1 and methods based thereon |
12/09/1999 | WO1999063093A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
12/09/1999 | WO1999063092A1 Root-specific protein involved in auxin transport |
12/09/1999 | WO1999063091A1 Disulfide core polypeptides |
12/09/1999 | WO1999063090A2 Protease inhibitor peptides |
12/09/1999 | WO1999063089A1 Cyclin e2 genes and proteins |
12/09/1999 | WO1999063088A2 Membrane-bound proteins and nucleic acids encoding the same |
12/09/1999 | WO1999063087A1 G-protein coupled receptor, named 2871 receptor |
12/09/1999 | WO1999063086A2 Insulin-like growth factor binding protein-3 variants |
12/09/1999 | WO1999063085A1 IgA NEPHROPATHY-ASSOCIATED DNA |
12/09/1999 | WO1999063084A1 T cell antigen receptor sequences specific to arthrosis deformans |
12/09/1999 | WO1999063083A1 Novel gene and protein encoded thereby |
12/09/1999 | WO1999063082A2 Isolation of drosophila homolog to mammalian gdnf |
12/09/1999 | WO1999063081A2 Ion channels |
12/09/1999 | WO1999063080A1 HUMAN HOMOLOGUE OF UNC-53 PROTEIN OF $i(C. ELEGANS) |
12/09/1999 | WO1999063079A1 Endometriosis-associated gene |
12/09/1999 | WO1999063078A2 Retinal calcium channel (alpha)1f-subunit gene |
12/09/1999 | WO1999063071A2 Method for triggering apoptosis in cells |
12/09/1999 | WO1999063068A1 Phenotype modifying genetic sequences |
12/09/1999 | WO1999063063A1 Cellular proteins which mediate herpesvirus entry |
12/09/1999 | WO1999063062A1 Genetically manipulated entomopoxvirus |
12/09/1999 | WO1999063054A2 Mutant forms of the al2 gene of geminiviruses |
12/09/1999 | WO1999062956A1 Angiopoietin related gene sequence scarface 3 |
12/09/1999 | WO1999062955A1 Method of designing agonists and antagonists to egf receptor family |
12/09/1999 | WO1999062954A1 A HUMAN MAGO GENE (h-MAGO) |
12/09/1999 | WO1999062953A1 A human leucine zipper protein gene (bmh) (cblayd06) |
12/09/1999 | WO1999062952A1 A human zinc finger protein gene (bmzf2) |
12/09/1999 | WO1999062951A1 A human zinc finger protein gene (bmzf3) |
12/09/1999 | WO1999062945A2 Peptide antigens for detection of hiv, hcv and other microbial infections |
12/09/1999 | WO1999062944A2 Protein oligomer compositions comprising endostatin protein and methods of using the same |
12/09/1999 | WO1999062943A2 Novel molecules of the aip-related protein family and uses thereof |
12/09/1999 | WO1999062942A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
12/09/1999 | WO1999062941A2 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
12/09/1999 | WO1999062939A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
12/09/1999 | WO1999062938A2 Polypeptides, traditionally of the human herpes virus type 8 and the diagnostic and medical application thereof |
12/09/1999 | WO1999062936A1 Separation of protein monomers from aggregates by use of ion-exchange chromatography |
12/09/1999 | WO1999062934A1 Interferon receptor hkaef92 |
12/09/1999 | WO1999062932A2 INHIBITION OF VIRAL INFECTION AND SPREAD WITH VIRAL AND RhoA-DERIVED PEPTIDES |
12/09/1999 | WO1999062931A2 A cell density signal protein suitable for treatment of connective tissue injuries and defects |
12/09/1999 | WO1999062927A1 Connective tissue growth factor-4 |
12/09/1999 | WO1999062925A1 Angiopoietin related gene sequence scarface 1 |
12/09/1999 | WO1999062919A1 Redox reversible bipyridyl osmium complex conjugates |
12/09/1999 | WO1999062918A1 Redox reversible imidazole-osmium complex conjugates |
12/09/1999 | WO1999062561A2 Gene therapy method |
12/09/1999 | WO1999062556A1 Eosinophil chemotactic factor |
12/09/1999 | WO1999062548A1 Methods and compositions for diagnosing tauopathies |
12/09/1999 | WO1999062547A1 HUMAN MINOR VAULT PROTEIN p193 |
12/09/1999 | WO1999062541A1 Immunosuppressants containing clusterins |
12/09/1999 | WO1999062537A1 Methods and agents for modulating the immune response and inflammation involving monocyte and dendritic cell membrane proteins |
12/09/1999 | WO1999062534A1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
12/09/1999 | WO1999062527A1 nrdE |
12/09/1999 | WO1999062526A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
12/09/1999 | WO1999062494A2 Membrane-permeable inhibitor of dynamin-mediated endocytosis |
12/09/1999 | WO1999062332A1 TRANSGENIC ANIMALS LACKING A FUNCTIONAL GFRα2 RECEPTOR AS WELL AS METHODS FOR THEIR PRODUCTION AND USE |
12/09/1999 | WO1999054487A3 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based dna library. application to the detection of mycobacteria |
12/09/1999 | WO1999054437A3 Novel molecules of the t125-related protein family and uses thereof |
12/09/1999 | WO1999053067A3 Seed-coat promoters, genes and gene products |
12/09/1999 | WO1999052938A3 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites |
12/09/1999 | WO1999051754A9 Infectious pseudotyped lentiviral vectors lacking matrix protein and uses thereof |
12/09/1999 | WO1999051749A3 Recombinant potyvirus construct and use thereof |
12/09/1999 | WO1999051275A3 Mesenchymal stem cells as immunosuppressants |
12/09/1999 | WO1999051266A3 Derivatives of pneumococcal choline binding proteins for vaccines |
12/09/1999 | WO1999051264A3 Leishmania cysteine proteinases |
12/09/1999 | WO1999050427A3 Novel basal endosperm transfer cell layer (betl) specific genes |
12/09/1999 | WO1999050290A9 Para-poxvirus-coded vascular endothelial cell growth factor (ppv-vegf) |
12/09/1999 | WO1999049885A3 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
12/09/1999 | WO1999048917A3 Formulation having a papilloma virus-specific protein, and the production and use thereof |
12/09/1999 | WO1999048486A3 Plant cell cyclin genes |
12/09/1999 | WO1999047678A3 Interferon alpha plasmids and delivery systems, and methods of making and using the same |
12/09/1999 | WO1999047657A3 Lactobacilli harboring aggregation and mucin binding genes as vaccine delivery vehicles |
12/09/1999 | WO1999046367A3 Methods of diagnosis and triage using cell activation measures |
12/09/1999 | WO1999045117A3 Interferon, ifn-hy and uses thereof |
12/09/1999 | WO1999038973A3 Compounds for therapy and diagnosis of lung cancer and methods for their use |
12/09/1999 | WO1999036536A3 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system |
12/09/1999 | WO1999024574A3 Plant homologs of yeast pad1, yeast crm1, and human jab1: regulators of ap-1 type transcription factor activity |
12/09/1999 | DE19825621A1 Protein zur Regulation von Apoptose Protein for regulation of apoptosis |
12/09/1999 | DE19825494A1 Neuer Angiotensin Rezeptor, Herstellung und Verwendung desselben The same new angiotensin receptor preparation and use |
12/09/1999 | DE19825447A1 Neue Insulinanaloga mit erhöhter Zinkbildung New insulin analogues with increased zinc Education |
12/09/1999 | DE19824811A1 Verfahren zur Auslösung von Apoptose in Zellen Method for triggering of apoptosis in cells |
12/09/1999 | DE19824492A1 Receptor-binding domain useful for identifying new substances for plant protection, hygiene or veterinary medicine |